Безопасен ли naringenin при беременности?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
Pregnancy-safe products containing naringenin










Related ingredients
Frequently asked questions
- Безопасен ли naringenin при беременности?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for naringenin (CAS 480-41-1). Peer‑reviewed literature shows naringenin is a dietary citrus flavanone with some in vitro endocrine-related activity reported, but no consistent animal or human developmental/teratogenic signal that would trigger H361/H360 classification; therefore hazard and mechanism are scored 0. Percutaneous absorption from topical application is plausible (low, not negligible) given naringenin’s physicochemical properties and presence in cosmetic formulations, so exposure is scored as low but measurable (e=1). Sources consulted: ECHA (no harmonised CLP entry), PubChem, PubMed, CosIng, EWG.
- Безопасен ли naringenin при грудном вскармливании?
- Same rationale as for pregnancy: no harmonised reproductive classification and no authoritative CIR/SCCS contraindication identified. Potential for low systemic absorption after topical use implies low measurable exposure in breastfeeding parent (e=1). No specific data on milk transfer were found in the authoritative sources consulted.
- Безопасен ли naringenin для кожи малыша?
- No infant‑specific developmental toxicity or dermal‑toxicity data indicating increased hazard. Following the specified instruction to increase exposure for infants when adult topical absorption is measurable, baby exposure is increased by +1 (adult e=1 → baby e=2) because infant skin has higher permeability and greater surface‑area‑to‑weight ratio. Hazard and mechanism remain 0 in absence of infant‑specific evidence.
- Как VeriMom оценивает naringenin?
- VeriMom оценивает naringenin в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы naringenin при беременности?
- См. наш список безопасных альтернатив naringenin с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.